Trials / Not Yet Recruiting
Not Yet RecruitingNCT07492303
A Phase I Clinical Trial of Absorbed Acellular Pertussis (Two-Component) Diphtheria-Tetanus Combined Vaccine (For Adults and Adolescents)
A Phase I Clinical Trial to Evaluate the Safety and Immunogenicity of Different Doses of Adsorbed Acellular Pertussis (Two-component) Diphtheria-tetanus Combined Vaccine (for Adults and Adolescents) in People Aged 10 Years and Older in a Randomized, Blinded, Placebo-controlled Manner
- Status
- Not Yet Recruiting
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 96 (estimated)
- Sponsor
- Changchun BCHT Biotechnology Co. · Industry
- Sex
- All
- Age
- 10 Years
- Healthy volunteers
- Accepted
Summary
the safety and tolerability of different dosages of adsorbed acellular pertussis (two-component) diphtheria-tetanus combined vaccine
Detailed description
14day and 30 days after exemption
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BIOLOGICAL | Tdap vaccine | intramuscular injection only, and the preferred inoculation site is the deltoid muscle of the upper arm. |
Timeline
- Start date
- 2026-04-20
- Primary completion
- 2026-07-10
- Completion
- 2027-08-20
- First posted
- 2026-03-25
- Last updated
- 2026-03-25
Source: ClinicalTrials.gov record NCT07492303. Inclusion in this directory is not an endorsement.